EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitiligo—Current Treatment Options and Future Perspectives

Aleksandra Wojno, Agata Wojno, Anna Karwowska iD, Milena Chmielewska iD, Joanna Maj, Magdalena Łyko iD

International Journal of Molecular Sciences · 17.07.2026 · 27 (14) · 6374

DOI: 10.3390/ijms27146374 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.07.2026. Verfasst von Aleksandra Wojno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Group of Experimental Dermatology, University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 …. Hauptthemen laut MEDLINE: Vitiligo. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is a chronic autoimmune disease characterized by the loss of melanocytes, resulting in the appearance of depigmented patches on the skin. The aim of the present review is to discuss current therapeutic methods and to outline promising directions for the treatment of this dermatosis. The review describes pathogenetic mechanisms, including the role of oxidative stress, immune dysregulation, and the JAK/STAT pathways, which constitute the foundation of contemporary therapeutic interventions. The efficacy and safety of topical treatments (corticosteroids, calcineurin inhibitors, JAK inhibitors), phototherapy (NB-UVB, PUVA, excimer laser), combination therapies, and surgical methods such as cellular and tissue grafts are discussed. Data indicate that the combination of phototherapy with topical agents enhances repigmentation efficacy, and JAK inhibitors represent promising drugs in targeted therapy. Particular value is attributed to preparations modulating the immune response and to melanocyte transplantation techniques, which emerge as highly effective and forward-looking treatment options for vitiligo. Nevertheless, effective management of vitiligo requires a multidirectional approach combining pharmacological, immunomodulatory, and regenerative interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoHumansMelanocytesAnimalsPhototherapyCalcineurin InhibitorsCombined Modality TherapyPUVA Therapy

Stichwörter der Autor:innen

JAK inhibitorscalcineurin inhibitorscombination therapymelanocyte transplantationphototherapyrepigmentationruxolitinibvitiligo

Substanzen

Calcineurin Inhibitors

Autor:innen und Institutionen

  • Student Research Group of Experimental Dermatology, University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wrocław, Poland.
  • University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wrocław, Poland.

ORCID-Profile: Anna Karwowska, Milena Chmielewska, Magdalena Łyko

Förderung

  • Wroclaw Medical University

Zitieren

APA

Wojno, A., Wojno, A., Karwowska, A., Chmielewska, M., Maj, J., & Łyko, M. (2026). Vitiligo—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences, 27(14), 6374. https://doi.org/10.3390/ijms27146374

Vancouver

Wojno A, Wojno A, Karwowska A, Chmielewska M, Maj J, Łyko M. Vitiligo—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences. 2026;27(14):6374. doi:10.3390/ijms27146374

BibTeX
@article{Wojno2026,
  author = {Wojno, Aleksandra and Wojno, Agata and Karwowska, Anna and Chmielewska, Milena and Maj, Joanna and Łyko, Magdalena},
  title = {Vitiligo—Current Treatment Options and Future Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6374},
  doi = {10.3390/ijms27146374}
}
Kostenlos starten →